Difference between revisions of "Part:BBa K3771006"

 
(12 intermediate revisions by 4 users not shown)
Line 4: Line 4:
  
 
<br><b style="font-size:1.3rem">Description</b>
 
<br><b style="font-size:1.3rem">Description</b>
<p>JJU (cysteine lyase) is an enzyme weighing approximately 43.1 kDa. JJU catalyzes the beta replacement reaction of L-cysteine and sulfite to form L-cysteate and hydrogen sulfide[1].</p>
+
<p>JJU (cysteine lyase) is an enzyme weighing approximately 45.1 kDa. JJU catalyzes the beta replacement reaction of L-cysteine and sulfite to form L-cysteate and hydrogen sulfide[1].</p>
  
<br><b style="font-size:1.3rem">Biology</b>
 
<p>The three taurine production pathways incorporated into our <i>E. coli</i> include the L-cysteine sulfinic acid pathway, L-cysteine sulfonic acid pathway, and the JJU-CoaBC pathway[1,2].</p>
 
  
 +
<br><b style="font-size:1.3rem">Usage</b>
 +
<br>JJU enzyme was used <i>in vitro</i> testing of taurine production. The sequence for JJU enzyme and trc promoter were ligated and transformed into <i>E. coli</i> to calculate taurine production using high-performance liquid chromatography (HPLC). A 6xHis-tag is added to the C-terminal of the JJU protein, allowing for confirmation of JJU expression by western blot using the anti-6xHis antibody.<br>
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:50%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 1. Taurine pathways in <i>E. coli</i> [1,2].</p>
  
<html><div style="width=100%; display:flex; align-items: center; justify-content: center;">
+
<p>JJU is an enzyme that is part of the JJU-CoaBC taurine production pathway, one of three possible taurine synthesis pathways. Its main function is to convert L-cysteine to L-cystate, which then becomes taurine by CoaBC[1]. </p>
<img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:50%;"></html>
+
<p>JJU10 is an enzyme in the JJU10-CoaBC pathway, one of three possible taurine synthesis pathways. Its main function is to convert L-cysteine to L-cystate.</p>
+
  
  
 +
 +
 +
<br><b style="font-size:1.3rem">Characterization</b>
 +
 +
<html>
 +
The <i>jju</i> sequence synthesized by IDT was amplified by PCR and ligated to <i>trc</i> promoter (<a href="https://parts.igem.org/Part:BBa_K864400" alt="" target="_blank">BBa_K864400</a>)  in the pET28a cloning vector.<br>
 +
</html>
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/1/1b/T--NCKU_Tainan--jjuhis.jpg
 +
" style="width:35%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 2. Agarose gel electrophoresis results showing amplified <i>jju</i> gene fragment</p>
 +
 +
 
 +
<br><b style="font-size:1.1rem">Taurine Production of JJU in <i>E. coli</i> BL21(DE3) strain</b>
 +
<br>
 +
 +
<br>In our <i>in vitro</i> testing of taurine production by JJU, JJU was transformed into <i>E. coli</i> BL21(DE3) strain. Supernatant (S) and whole cell (WC) samples were collected to confirm extracellular and intracellular protein expression by SDS-PAGE. <br>
 +
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/8/80/T--NCKU_Tainan--invitro1-PAGE.png" style="width:50%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 3. Confirmation of JJU expression by SDS-PAGE. M: Marker; Lane 1: whole cell of JJU in BL21(DE3); Lane 2: soluble protein of JJU in BL21(DE3) (~43 kDa);
 +
Lane 3: whole cell of CoaBC in BL21(DE3); Lane 4: soluble protein of CoaBC in BL21(DE3) (~45.1 kDa)</p>
 +
 +
<br>Whole cell and supernatant JJU and CoaBC samples were collected and added in a JJU:CoaBC volume ratio of 1:1, 2:1, and 1:2. High-performance liquid chromatography (HPLC) was conducted to determine taurine concentration. Because JJU concentrations were lower, two times as much JJU supernatant volume compared to CoaBC supernatant volume was required to produce a significant amount of taurine. As shown in Fig. 2, 2:1 ratio of JJU to CoaBC supernatant volume had the highest taurine concentration of around 95 mg/L. <br>
 +
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/2/27/T--NCKU_Tainan--invitro1.png" style="width:50%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 4. Taurine production of both JJU and CoaBC in BL21(DE3) in whole cell and soluble protein samples</p>
 +
 +
<b style="font-size:1.1rem">Taurine Production of JJU in <i>E. coli</i> BD7G strain</b>
 +
 +
<br>Since JJU expression in BL21(DE3) strain was not prominent in the supernatant, we performed another <i>in vitro</i> test in which <i>P<sub>T7</sub>-jju</i> was transformed into BD7G strain instead of the BL21(DE3) strain. The BD7G strain contains chaperone protein GroELS that aids in protein folding [1]. SDS-PAGE results confirm JJU expression in both supernatant and whole cell samples.<br>
 +
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/6/63/T--NCKU_Tainan--invitro2-PAGE.png" style="width:50%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 5. Confirmation of JJU expression by SDS-PAGE. M: Marker; Lane 1: whole cell of JJU in BD7G; Lane 2: soluble protein of JJU in BD7G (~43 kDa);
 +
Lane 3: whole cell of CoaBC in BL21(DE3); Lane 4: soluble protein of CoaBC in BL21(DE3) (~45.1 kDa)</p>
 +
 +
<br>The whole cell and supernatant JJU and CoaBC samples are collected and added in a JJU:CoaBC volume ratio of 1:1, 2:1, and 1:2. When <i>P<sub>T7</sub>-jju</i> was transformed into the BD7G strain, 1:1 ratio of JJU to CoaBC supernatant had the highest taurine production, as shown in Fig. 6. This suggests the activity level of JJU does not significantly differ from that of CoaBC, and both are equally crucial and effective in converting L-cysteine to taurine.<br>
 +
 +
<html>
 +
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 +
  <img src="https://2021.igem.org/wiki/images/9/9d/T--NCKU_Tainan--invitro2.png" style="width:50%;">
 +
</div>
 +
</html>
 +
<p align="center">Fig. 6. Taurine production of JJU in BD7G and CoaBC in BL21(DE3) in soluble protein samples</p>
 +
 +
 
 +
<br><b style="font-size:1.3rem">References</b>
 +
<br>
 +
<br>BRENDA - Information on EC 4.4.1.10 - cysteine lyase. Brenda-enzymes.org. Published 2021. Accessed October 6, 2021. https://www.brenda-enzymes.org/enzyme.php?ecno=4.4.1.10<br>
 +
 
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===

Latest revision as of 03:44, 22 October 2021


JJU-6xHis


Description

JJU (cysteine lyase) is an enzyme weighing approximately 45.1 kDa. JJU catalyzes the beta replacement reaction of L-cysteine and sulfite to form L-cysteate and hydrogen sulfide[1].



Usage
JJU enzyme was used in vitro testing of taurine production. The sequence for JJU enzyme and trc promoter were ligated and transformed into E. coli to calculate taurine production using high-performance liquid chromatography (HPLC). A 6xHis-tag is added to the C-terminal of the JJU protein, allowing for confirmation of JJU expression by western blot using the anti-6xHis antibody.

Fig. 1. Taurine pathways in E. coli [1,2].

JJU is an enzyme that is part of the JJU-CoaBC taurine production pathway, one of three possible taurine synthesis pathways. Its main function is to convert L-cysteine to L-cystate, which then becomes taurine by CoaBC[1].




Characterization

The jju sequence synthesized by IDT was amplified by PCR and ligated to trc promoter (BBa_K864400) in the pET28a cloning vector.

Fig. 2. Agarose gel electrophoresis results showing amplified jju gene fragment



Taurine Production of JJU in E. coli BL21(DE3) strain


In our in vitro testing of taurine production by JJU, JJU was transformed into E. coli BL21(DE3) strain. Supernatant (S) and whole cell (WC) samples were collected to confirm extracellular and intracellular protein expression by SDS-PAGE.

Fig. 3. Confirmation of JJU expression by SDS-PAGE. M: Marker; Lane 1: whole cell of JJU in BL21(DE3); Lane 2: soluble protein of JJU in BL21(DE3) (~43 kDa); Lane 3: whole cell of CoaBC in BL21(DE3); Lane 4: soluble protein of CoaBC in BL21(DE3) (~45.1 kDa)


Whole cell and supernatant JJU and CoaBC samples were collected and added in a JJU:CoaBC volume ratio of 1:1, 2:1, and 1:2. High-performance liquid chromatography (HPLC) was conducted to determine taurine concentration. Because JJU concentrations were lower, two times as much JJU supernatant volume compared to CoaBC supernatant volume was required to produce a significant amount of taurine. As shown in Fig. 2, 2:1 ratio of JJU to CoaBC supernatant volume had the highest taurine concentration of around 95 mg/L.

Fig. 4. Taurine production of both JJU and CoaBC in BL21(DE3) in whole cell and soluble protein samples

Taurine Production of JJU in E. coli BD7G strain


Since JJU expression in BL21(DE3) strain was not prominent in the supernatant, we performed another in vitro test in which PT7-jju was transformed into BD7G strain instead of the BL21(DE3) strain. The BD7G strain contains chaperone protein GroELS that aids in protein folding [1]. SDS-PAGE results confirm JJU expression in both supernatant and whole cell samples.

Fig. 5. Confirmation of JJU expression by SDS-PAGE. M: Marker; Lane 1: whole cell of JJU in BD7G; Lane 2: soluble protein of JJU in BD7G (~43 kDa); Lane 3: whole cell of CoaBC in BL21(DE3); Lane 4: soluble protein of CoaBC in BL21(DE3) (~45.1 kDa)


The whole cell and supernatant JJU and CoaBC samples are collected and added in a JJU:CoaBC volume ratio of 1:1, 2:1, and 1:2. When PT7-jju was transformed into the BD7G strain, 1:1 ratio of JJU to CoaBC supernatant had the highest taurine production, as shown in Fig. 6. This suggests the activity level of JJU does not significantly differ from that of CoaBC, and both are equally crucial and effective in converting L-cysteine to taurine.

Fig. 6. Taurine production of JJU in BD7G and CoaBC in BL21(DE3) in soluble protein samples



References

BRENDA - Information on EC 4.4.1.10 - cysteine lyase. Brenda-enzymes.org. Published 2021. Accessed October 6, 2021. https://www.brenda-enzymes.org/enzyme.php?ecno=4.4.1.10

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]